Reassessing Recipient Mortality Under the New Heart Allocation System
Oliver K. Jawitz(Clinical Research Institute), Joseph G. Rogers(Baylor College of Medicine), Robert J. Mentz(Duke University), Carmelo A. Milano(Duke University Hospital), Jacob N. Schroder(Duke University), Chetan B. Patel, Adam D. DeVore(Duke University), Vignesh Raman(WakeMed), Benjamin S. Bryner(Northwestern University), Marat Fudim(Clinical Research Institute)
Cited by 114
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Telehealth transformation: COVID-19 and the rise of virtual care
|Journal of the American Medical Informatics Association|2020|1.6k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k